OUR PRODUCTS

MOBILE APPS

GENERAL INFO

IFRX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

InflaRx (IFRX) Earnings Date & Reports

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IFRX is expected to report earnings to fall 20.62% to -16 cents per share on October 30

Q3'25

Est.

$-0.17

Q2'25

Missed

by $0.04

Q1'25

Beat

by $0.04

Q4'24

Beat

by $0.16

Q3'24

Missed

by $0.05

The last earnings report on August 07 showed earnings per share of -20 cents, missing the estimate of -17 cents. With 161.54K shares outstanding, the current market capitalization sits at 54.21M.

View a ticker or compare two or three

Compare

IFRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IFRX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IFRX showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Winzerlaer Strasse 2

Phone

+49 3641508180

Employees

Web

https://www.inflarx.de